More on OGN
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $6.71 |
|
|||
| Open | $6.66 | ||||
| 52 Wk High | $8.00 | ||||
| 52 Wk Low | $8.00 | ||||
| Day High | $6.67 | ||||
| Day Low | $6.53 | ||||
| P/E | N/A | ||||
| EPS | $0.00 | ||||
| Volume | 2,546,683 | ||||
- Form 4 Organon & Co. For: Feb 27 Filed by: Falcione Aaron
- Form 4 Organon & Co. For: Feb 27 Filed by: WALSH MATTHEW M
- Form 4 Organon & Co. For: Feb 27 Filed by: Nisita Vittorio
- Form 4 Organon & Co. For: Feb 27 Filed by: Stahler Rachel A
- Form 4 Organon & Co. For: Feb 27 Filed by: Weaver Kirke
- Form 4 Organon & Co. For: Feb 27 Filed by: Morrissey Joseph T. Jr.
- Organon's VTAMA cream shows sleep improvements in pediatric atopic dermatitis study
- New Analysis of Organon’s VTAMA® (tapinarof) cream, 1%, Phase 3 Data Showed Early and Consistent Improvement in Patient-Reported Sleep Subdomains in Pediatric Patients Down to 2 Years of Age with A
- Form 10-K Organon & Co. For: Dec 31
- Organon & Co. (OGN) PT Raised to $8 at Barclays
Entities mentioned with OGN
- Definitive Agreement | View Related Stories »
- Dividend | View Related Stories »
- ARK | View Related Stories »
- Earnings | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- Twitter | View Related Stories »
- FDA | View Related Stories »
- Show More...
